+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Immunoassay Systems - Global Strategic Business Report

  • ID: 338902
  • Report
  • March 2017
  • Region: Global
  • 334 Pages
  • Global Industry Analysts, Inc
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories (USA)
  • BioMérieux SA (France)
  • DiaSorin S.p.A (Italy)
  • Fujirebio, Inc. (Japan)
  • Quidel Corporation (USA)
  • MORE

This report analyzes the worldwide markets for Immunoassay Systems in US$ Thousand by the following Technology Segments: Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 65 companies including many key and niche players such as:

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
Note: Product cover images may vary from those shown
2 of 5

Loading
LOADING...

3 of 5

FEATURED COMPANIES

  • Abbott Laboratories (USA)
  • BioMérieux SA (France)
  • DiaSorin S.p.A (Italy)
  • Fujirebio, Inc. (Japan)
  • Quidel Corporation (USA)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Enzyme Immunoassay
Fluorescence Immunoassay
Chemiluminescence Immunoassay
Rapid Tests
Elispot
Others

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Immunoassays
A Preface
Current and Future Analysis
Factors Sustaining Market Growth
Factors Restraining Growth
Developing Markets to Drive Sales
Radioimmunoassay Systems Lose Ground
Chemiluminescence Immunoassays Gain Demand
Expanding Immunoassay Applications Boost Demand
Table 1: Global Laboratory Based Immunoassay Market (2016): Percentage Share Breakdown of Value Sales by Clinical Area (includes corresponding Graph/Chart)

2. COMPETITIVE LANDSCAPE
Table 2: Leading Players in the Global Immunoassay Systems Market (2015)
Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)

3. MARKET TRENDS AND ISSUES
Bespoke Solutions Energize Market Growth
Multiplex Immunoassays Grow in Demand
Novel Biomarkers to Boost Market Growth
SERS
An Attractive Readout Strategy
Automated Immunoassay Systems
In Line with Automation Trend
Technological Advances to buoy ELISA’s Prospects
Automation of ELISA
Enabling its Sustenance
Growing Popularity of Multiplexing Deters ELISA Market
Commoditization: A Key Issue Facing ELISA Product Manufacturers
Consolidation of Hospitals and Labs Drives Demand
POC and DIA Systems Grow in Demand
Prenatal Testing
An Opportunity Market
Rise in Infectious Diseases Raises Demand
Increasing Use of Immunoassays in Food Sciences and Quality Control
Growing Use in Environmental Testing

4. MACRO GROWTH DRIVERS AND APPLICATION MARKETS
Improving Healthcare Expenditure to Foster Growth
Table 3: Healthcare Spending as % of GDP by Region (2017E) (includes corresponding Graph/Chart)
Aging Global Population Buoys Market Growth
Table 4: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Infectious Disease Diagnosis: The Largest Application Area
Increasing Incidence of Infectious Diseases
An Opportunity Indicator
Table 5: Reported Cases of Major Infections by Select Geographic Region: 2011
Endocrine Testing Procedures
Growing Diabetes Prevalence Boost Prospects for Immunoassay- based HbA1c Tests
Table 6: Worldwide Prevalence of Diabetes Mellitus by Region (2013 & 2035) (includes corresponding Graph/Chart)
Table 7: Incidence of Diabetes in Select Countries (2015 & 2040) (includes corresponding Graph/Chart)
Blood Processing Market
Cancer Testing Markets
Drugs of Abuse Testing Market
Therapeutic Drug Monitoring
Immune Disease
Blood Grouping and Typing

5. CONCEPTUAL OVERVIEW
Immunoassays
Definition and Description
Down the Timeline
Immunoassay Analyzers
Immunoassay Reagents
Components of Immunoassays
Signal Response
Labeled Tracer
Binder
Buffer Matrix
Incubation Conditions
Separation Process
Standard Specimens
Control Specimens
Unknown Specimens
Types of Immunoassay Analyzers
An Insight Into Immunoassay Technologies
Enzyme Immunoassays (EIA)
ELISA
A Renowned and Proven Assay Format
Fluorescence Immunoassay
Operating Principle
Chemiluminescence Immunoassay
Radioimmunoassay Analyzers, Gamma Counters
Rapid Tests
ELISPOT
Western Blot
Comparison of Various Immunoassay Technologies
Purchase Considerations for Analyzers

6. PRODUCT LAUNCHES/APPROVALS
Sekisui Diagnostics Launches new SEKURE® TPLA and RPR Assays for Syphilis Testing
Siemens Healthineers Introduces Atellica Solution automated Immunoassay Analyzer System
Abbott Introduces Alinity™
Roche Introduces New Cobas e 801 Module
Siemens to Release Genetic Assay for Detection of Zika Virus
Fujirebio Europe Releases the Lumipulse G B - R - A - H - M - S PCT Assay
Fujirebio Releases "Lumipulse L 2400" CLIA System
Roche Introduces Elecsys® HTLV-I/II Immunoassay
Siemens Introduces ADVIA Centaur Syphilis Assay
Sysmex Introduces HISCL-800 Automated Immunoassay System
Siemens Introduces New Chemistry & Immunoassay Systems
Meso Scale Discovery Launches S-PLEX™ Assays
Modern Water Monitoring Introduces New Immunoassay Strip Test and Readers
Enzo Life Sciences Launches Amp'd™ ELISA Signal Amplification Kit
EMD Millipore Rolls Out New Immunoassay Kits
PerkinElmer Launches Novel Research Tools
Roche Releases Elecsys Syphilis Immunoassay

7. RECENT INDUSTRY ACTIVITY
Abbott Receives CE Mark for Alinity CI-Series Diagnostic Systems
Quidel Receives FDA Clearance for New Solana(R) Molecular Assay
Quidel Receives FDA Clearance for Solana(R) Strep Complete Assay
FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs
Beckman Coulter Receives FDA Clearance for Access TSH (3rd IS) Assay
Quidel Receives FDA Clearance for Solana(R) Influenza A+B Assay
Ortho Clinical Diagnostics Receives CE Mark Approval for VITROS® Immunodiagnostic HIV Combo Test
Siemens Healthcare Changes Name to Siemens Healthineers
DiaSorin to Acquire Focus Diagnostics' Molecular and Immunoassay Product Business
Quidel Receives CE Mark for Quidel's Sofia® S. pneumoniae Fluorescent Immunoassay
DiaSorin and Beckman Coulter Sign Agreement to Distribute Hepatitis and HIV Tests in China
bioMérieux Receives FDA 510(k) clearance for VIDAS® 3
Quidel Receives FDA Clearance for New Solana™ Molecular System and Solana™ Molecular Assay
Siemens Receives FDA Approval for Siemens HIV Combo assay
Eurofins Acquired ViraCor-IBT Laboratories
YSL Bio Signs Enters into Agreement with GeneX
Techne to Acquire CyVek
Gyros Enters into Distribution Agreement with Tekon Biotech
Singulex Partners with Tecan
OriGene Technologies Takes Over BioCheck
Techne Partners with Fisher Scientific

8. FOCUS ON SELECT MARKET PARTICIPANTS
Abbott Laboratories (USA)
Beckman Coulter, Inc. (USA)
bioMérieux SA (France)
Bio-Rad Laboratories Inc. (USA)
DiaSorin S.p.A (Italy)
Fujirebio, Inc. (Japan)
Ortho-Clinical Diagnostics, Inc. (USA)
Roche Diagnostics (Switzerland)
Siemens Healthineers (USA)
Sysmex Corporation (Japan)
Quidel Corporation (USA)
Tosoh Bioscience, Inc. (USA)

9. GLOBAL MARKET PERSPECTIVE
Table 8: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 9: World Historic Review for Immunoassay Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 10: World 14-Year Perspective for Immunoassay Systems by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Immunoassay Market by Technology
Table 11: World Recent Past, Current & Future Analysis for Enzyme Immunoassay by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 12: World Historic Review for Enzyme Immunoassay by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 13: World 14-Year Perspective for Enzyme Immunoassay by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 14: World Recent Past, Current & Future Analysis for Fluorescence Immunoassay Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 15: World Historic Review for Fluorescence Immunoassay Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 16: World 14-Year Perspective for Fluorescence Immunoassay Systems by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 17: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 18: World Historic Review for Chemiluminescence Immunoassay Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 19: World 14-Year Perspective for Chemiluminescence Immunoassay Systems by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 20: World Recent Past, Current & Future Analysis for Rapid Tests by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 21: World Historic Review for Rapid Tests by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 22: World 14-Year Perspective for Rapid Tests by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 23: World Recent Past, Current & Future Analysis for ELISPOT by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 24: World Historic Review for ELISPOT by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 25: World 14-Year Perspective for ELISPOT by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) Technology by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 27: World Historic Review for Polymerase Chain Reaction (PCR) Technology by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 28: World 14-Year Perspective for Polymerase Chain Reaction (PCR) Technology by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 29: World Recent Past, Current & Future Analysis for Other Immunoassays by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 30: World Historic Review for Other Immunoassays by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 31: World 14-Year Perspective for Other Immunoassays by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A. Market Analysis
Current and Future Analysis
Increasing Burden of Chronic Diseases Drives Focus onto Immunoassays
An Overview of ELISA Usage
Ageing Demographics: Major Driving Factor
Table 32: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Product Launches/Approvals
Strategic Corporate Developments
Focus on Select Players
B. Market Analytics
Table 33: US Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 34: US Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 35: US 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA
Market Analysis
Table 36: Canadian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37: Canadian Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 38: Canadian 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN
A. Market Analysis
Outlook
Product Launches
Focus on Key Players
B. Market Analytics
Table 39: Japanese Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 40: Japanese Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 41: Japanese 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE
A. Market Analysis
Current & Future Analysis
Automation Supports Growth in Western European IVD Market
Immunochemistry Analyzer Market
Recent Industry Activity
B. Market Analytics
Table 42: European Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region
France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 43: European Historic Review for Immunoassay Systems by Geographic Region
France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 44: European 14-Year Perspective for Immunoassay Systems by Geographic Region
Percentage Breakdown of Value Sales for France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 45: European Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 46: European Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 47: European 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE
A. Market Analysis
Current & Future Analysis
Biomérieux
A Key Player
B. Market Analytics
Table 48: French Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 49: French Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 50: French 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4b. GERMANY
A. Market Analysis
Current & Future Analysis
Product Launches
B. Market Analytics
Table 51: German Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 52: German Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 53: German 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4c. ITALY
A. Market Analysis
Diasorin S.p.A
A Key Player
B. Market Analytics
Table 54: Italian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 55: Italian Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 56: Italian 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
A. Market Analysis
Current & Future Analysis
Product Launch
B. Market Analytics
Table 57: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 58: UK Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 59: UK 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4e. SPAIN
Market Analysis
Table 60: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 61: Spain Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 62: Spain 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4f. RUSSIA
Market Analysis
Table 63: Russian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 64: Russian Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 65: Russian 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE
A. Market Analysis
Current and Future Analysis
Strategic Corporate Developments
Roche Diagnostics
A Key Player
B. Market Analytics
Table 66: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 67: Rest of Europe Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 68: Rest of Europe 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A. Market Analysis
Current and Future Analysis
Growing In-Vitro Diagnostics (IVD) Market Fuels Demand for Immunoassay Instruments
B. Market Analytics
Table 69: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 70: Asia-Pacific Historic Review for Immunoassay Systems by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 71: Asia-Pacific 14-Year Perspective for Immunoassay Systems by Geographic Region
Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 72: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 73: Asia-Pacific Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 74: Asia-Pacific 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5a. CHINA
A. Market Analysis
Current and Future Analysis
In-Vitro Diagnostics Market
Strategic Corporate Development
B. Market Analytics
Table 75: Chinese Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 76: Chinese Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 77: Chinese 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5b. INDIA
A. Market Analysis
Current and Future Analysis
Immunoassay Systems market
An Overview
Emerging Trends
B. Market Analytics
Table 78: Indian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 79: Indian Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 80: Indian 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC
A. Market Analysis
Current and Future Analysis
Indonesia
Malaysia
Strategic Corporate Developments
B. Market Analytics
Table 81: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 82: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 83: Rest of Asia-Pacific 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA
Market Analysis
Table 84: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 85: Latin American Historic Review for Immunoassay Systems by Geographic Region
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 86: Latin American 14-Year Perspective for Immunoassay Systems by Geographic Region
Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 87: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 88: Latin American Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 89: Latin American 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6a. BRAZIL
Market Analysis
Table 90: Brazilian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 91: Brazilian Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 92: Brazilian 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA
Market Analysis
Table 93: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 94: Rest of Latin America Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 95: Rest of Latin America 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD
Market Analysis
Table 96: Rest of World Recent Past, Current & Future Analysis for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 97: Rest of World Historic Review for Immunoassay Systems by Technology
Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 98: Rest of World 14-Year Perspective for Immunoassay Systems by Technology
Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 65 (including Divisions/Subsidiaries 88)

  • The United States (49)
  • Canada (1) Japan (7)
  • Europe (29)
    • France (3)
    • Germany (6)
    • The United Kingdom (5)
    • Italy (3)
    • Spain (1)
    • Rest of Europe (11)
  • Asia-Pacific (Excluding Japan) (2)
Note: Product cover images may vary from those shown
4 of 5
  • Abbott Laboratories (USA)
  • Beckman Coulter, Inc. (USA)
  • Bio-Rad Laboratories Inc. (USA)
  • BioMérieux SA (France)
  • DiaSorin S.p.A (Italy)
  • Fujirebio, Inc. (Japan)
  • Ortho-Clinical Diagnostics, Inc. (USA)
  • Quidel Corporation (USA)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (USA)
  • Sysmex Corporation (Japan)
  • Tosoh Bioscience, Inc. (USA)
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll